跳至主要内容
临床试验/NCT04466566
NCT04466566已完成3 期

Effect of Genetic Variation in the GLP-1 Receptor on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetic Humans

Adrian Vella1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2022年10月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Adrian Vella
入组人数
21
试验地点
1
主要终点
Insulin secretion quantified using the minimal model to generate an index of beta-cell responsivity (Φ)

研究概览

简要总结

The GLP-1 receptor (GLP1R) gene is found on the beta cells of the pancreas. Its role is in the control of blood sugar level by enhancing insulin secretion from the pancreas after eating a meal. The purpose of this research study to find out how genetic variations in GLP1R alter insulin secretion, in the fasting state and when blood sugars levels are elevated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 40 nondiabetic subjects will be recruited.
  • 20 subjects with the AA genotype at rs3765467 and remainder will have the GG genotype.
  • Individuals encompassing the age span of 25-65 years.

排除标准

  • Individuals under 25 and over 65 years of age.

研究组 & 干预措施

Saline

Placebo Comparator

Saline will be infused during the study

干预措施: Saline (Other)

Exendin-9,39

Active Comparator

Exendin-9,39 will be infused during the study

干预措施: Exendin-9,39 (Biological)

结局指标

主要结局

Insulin secretion quantified using the minimal model to generate an index of beta-cell responsivity (Φ)

时间窗: This will be calculated from the 0-180 minute data of the study

次要结局

  • Glucagon secretion measured by immunoassay(This will be averaged over the 0-180 minute data of the study)

研究者

发起方
Adrian Vella
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Adrian Vella

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验